Advertisement
Screener

UFP Technologies, Inc. (UFPT) Scorecard

2.8 / 5 stars · 68/120 Roast Me

UFP Technologies, Inc. (UFPT) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
  • 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
76/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 WinUFPT / S&P
36.95% / 15.20%
LoseUFPT / S&P
7.32% / 15.00%
LoseUFPT / S&P
7.42% / 50.40%
2026-Q10/3 LoseUFPT / S&P
-12.80% / -4.33%
LoseUFPT / S&P
11.19% / 11.30%
LoseUFPT / S&P
7.72% / 27.70%
2025-Q43/3 WinUFPT / S&P
11.24% / 2.65%
WinUFPT / S&P
19.50% / 9.00%
WinUFPT / S&P
15.42% / 13.40%
2025-Q32/3 LoseUFPT / S&P
-18.25% / 8.12%
WinUFPT / S&P
29.47% / 4.61%
WinUFPT / S&P
23.14% / 13.45%
2025-Q23/3 WinUFPT / S&P
21.05% / 10.94%
WinUFPT / S&P
40.98% / 4.83%
WinUFPT / S&P
34.48% / 10.63%
2025-Q12/3 LoseUFPT / S&P
-17.50% / -4.27%
WinUFPT / S&P
34.43% / 4.98%
WinUFPT / S&P
31.40% / 10.57%
2024-Q42/3 LoseUFPT / S&P
-22.79% / 2.41%
WinUFPT / S&P
26.08% / 5.25%
WinUFPT / S&P
29.97% / 6.15%
2024-Q33/3 WinUFPT / S&P
20.02% / 5.89%
WinUFPT / S&P
18.48% / 5.89%
WinUFPT / S&P
29.15% / 6.11%
2024-Q22/3 WinUFPT / S&P
4.63% / 4.28%
WinUFPT / S&P
8.15% / 5.38%
LoseUFPT / S&P
-0.77% / 5.12%
2024-Q12/3 WinUFPT / S&P
46.59% / 10.56%
WinUFPT / S&P
7.11% / 5.71%
LoseUFPT / S&P
2.14% / 5.59%
2023-Q41/3 LoseUFPT / S&P
6.56% / 11.69%
WinUFPT / S&P
13.08% / 6.81%
LoseUFPT / S&P
7.16% / 7.78%
2023-Q32/3 LoseUFPT / S&P
-16.71% / -3.27%
WinUFPT / S&P
22.24% / 7.52%
WinUFPT / S&P
13.15% / -5.03%
2023-Q23/3 WinUFPT / S&P
49.30% / 8.74%
WinUFPT / S&P
41.57% / 9.50%
WinUFPT / S&P
136.63% / -8.57%
2023-Q13/3 WinUFPT / S&P
10.14% / 7.50%
WinUFPT / S&P
66.10% / 10.77%
WinUFPT / S&P
178.90% / -15.69%
2022-Q43/3 WinUFPT / S&P
37.34% / 7.56%
WinUFPT / S&P
71.48% / 11.88%
WinUFPT / S&P
160.77% / -17.99%
2022-Q33/3 WinUFPT / S&P
7.88% / -4.88%
WinUFPT / S&P
63.43% / 13.47%
WinUFPT / S&P
115.77% / -1.41%
2022-Q23/3 WinUFPT / S&P
20.25% / -16.10%
WinUFPT / S&P
45.25% / 13.71%
WinUFPT / S&P
28.77% / 11.04%
2022-Q11/3 LoseUFPT / S&P
-5.82% / -4.60%
WinUFPT / S&P
27.42% / 15.97%
LoseUFPT / S&P
20.44% / 42.23%
2021-Q42/3 WinUFPT / S&P
14.08% / 11.03%
WinUFPT / S&P
15.02% / 15.00%
LoseUFPT / S&P
17.42% / 96.40%
2021-Q31/3 WinUFPT / S&P
7.26% / 0.58%
LoseUFPT / S&P
5.77% / 10.77%
LoseUFPT / S&P
11.56% / 69.42%
2021-Q21/3 WinUFPT / S&P
15.25% / 8.55%
LoseUFPT / S&P
-1.51% / 6.58%
LoseUFPT / S&P
-9.40% / 51.81%
2021-Q11/3 WinUFPT / S&P
6.91% / 6.17%
LoseUFPT / S&P
-9.85% / -1.06%
LoseUFPT / S&P
-31.70% / 7.39%
2020-Q42/3 WinUFPT / S&P
12.51% / 12.15%
LoseUFPT / S&P
-9.58% / -3.72%
WinUFPT / S&P
-32.32% / -33.42%
2020-Q31/3 LoseUFPT / S&P
-5.99% / 8.93%
LoseUFPT / S&P
-7.21% / -2.04%
WinUFPT / S&P
-19.11% / -27.10%
2020-Q21/3 LoseUFPT / S&P
15.67% / 20.54%
LoseUFPT / S&P
-3.37% / -0.46%
WinUFPT / S&P
3.08% / -27.11%
2020-Q11/3 LoseUFPT / S&P
-23.22% / -19.60%
LoseUFPT / S&P
2.30% / 3.47%
WinUFPT / S&P
21.00% / -14.75%
2019-Q42/3 WinUFPT / S&P
28.52% / 9.07%
LoseUFPT / S&P
4.16% / 5.36%
WinUFPT / S&P
36.27% / 2.99%
2019-Q32/3 LoseUFPT / S&P
-7.23% / 1.70%
WinUFPT / S&P
12.34% / 5.02%
WinUFPT / S&P
43.86% / 0.21%
2019-Q23/3 WinUFPT / S&P
11.26% / 4.30%
WinUFPT / S&P
19.64% / 6.64%
WinUFPT / S&P
64.49% / 8.65%
2019-Q13/3 WinUFPT / S&P
24.50% / 13.65%
WinUFPT / S&P
26.76% / 8.12%
WinUFPT / S&P
82.50% / 14.29%
2018-Q42/3 LoseUFPT / S&P
-18.26% / -13.52%
WinUFPT / S&P
28.82% / 9.05%
WinUFPT / S&P
53.17% / 18.23%
2018-Q33/3 WinUFPT / S&P
19.12% / 7.71%
WinUFPT / S&P
20.29% / 10.21%
WinUFPT / S&P
55.45% / 19.06%
2018-Q22/3 WinUFPT / S&P
4.58% / 3.43%
WinUFPT / S&P
10.89% / 9.03%
LoseUFPT / S&P
11.29% / 14.46%
2018-Q11/3 WinUFPT / S&P
6.12% / -0.76%
LoseUFPT / S&P
3.39% / 7.68%
LoseUFPT / S&P
-4.76% / 12.46%
2017-Q40/3 LoseUFPT / S&P
-1.07% / 6.64%
LoseUFPT / S&P
1.17% / 7.03%
LoseUFPT / S&P
13.51% / 13.82%
2017-Q30/3 LoseUFPT / S&P
-0.71% / 4.48%
LoseUFPT / S&P
2.49% / 5.68%
LoseUFPT / S&P
-2.65% / 17.57%
2017-Q23/3 WinUFPT / S&P
9.27% / 3.09%
WinUFPT / S&P
5.60% / 4.83%
WinUFPT / S&P
19.23% / 17.74%
2017-Q12/3 LoseUFPT / S&P
1.77% / 6.07%
WinUFPT / S&P
6.68% / 3.67%
WinUFPT / S&P
28.57% / 13.32%
2016-Q41/3 LoseUFPT / S&P
-3.96% / 3.82%
WinUFPT / S&P
5.24% / 2.09%
LoseUFPT / S&P
4.72% / 7.05%
2016-Q33/3 WinUFPT / S&P
17.57% / 3.85%
WinUFPT / S&P
2.41% / 0.20%
WinUFPT / S&P
8.65% / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricUFPT total returnS&P 500 Total Return Index
Total return42.72%20.78%
Annualized return42.72%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricUFPT total returnS&P 500 Total Return Index
Total return334.46%83.14%
Annualized return34.15%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricUFPT total returnS&P 500 Total Return Index
Total return1096.45%319.30%
Annualized return28.17%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57